Lovastatin

Product NDC: 63629-1018
11-digit product format: 636291018
Labeler code: 63629
Product ID: 63629-1018_67bf8a65-3ac2-4e9c-a655-51f0717de716
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lovastatin
Dosage form: TABLET
Route: ORAL
Labeler: Bryant Ranch Prepack
Application: ANDA075991
Marketing category: ANDA
Marketing start: 2002-11-25
Substance: LOVASTATIN
Active strength: 10 mg/1
Pharmacologic classes: HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 10 matching rows.

View current auxiliary records. · View the auxiliary file history.

Dataset, Scope, Package NDC table
Dataset	Scope	Package NDC
excluded product	product
excluded package	package	63629-1018-3
excluded package	package	63629-1018-5
excluded package	package	63629-1018-1
excluded package	package	63629-1018-6
excluded package	package	63629-1018-9
excluded package	package	63629-1018-8
excluded package	package	63629-1018-4
excluded package	package	63629-1018-0
excluded package	package	63629-1018-2

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A075991-001	LOVASTATIN	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05
A075991-002	LOVASTATIN	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05
A075991-003	LOVASTATIN	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A075991-001	AB
A075991-002	AB
A075991-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A075991-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A075991-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A075991-003	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A075991-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075991-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075991-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A075991-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075991-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075991-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075991-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075991-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075991-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075991-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075991-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075991-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075991-001	AB	1	`301d65b070ca…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Lovastatin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LOVASTATIN	10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9LHU78OQFD	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
197903	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
c871a6a7-67a4-4ac1-b102-3f1604625c7d	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dc9a5fb6-14e2-1cc8-a567-a781fd1f0212	Product name	1	20140508
f1ae760e-e8ec-b0b4-fb1b-2db7c49fcec5	Product name	1	20140508
fecc3d5d-ff9a-60ad-1a3a-6cb9b21df758	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
63629-1018-0	2020-07-10	Lovastatin Tablet USP Revision M
63629-1018-1	2020-07-10	Lovastatin Tablet USP Revision M
63629-1018-2	2020-07-10	Lovastatin Tablet USP Revision M
63629-1018-3	2020-07-10	Lovastatin Tablet USP Revision M
63629-1018-4	2020-07-10	Lovastatin Tablet USP Revision M
63629-1018-5	2020-07-10	Lovastatin Tablet USP Revision M
63629-1018-6	2020-07-10	Lovastatin Tablet USP Revision M
63629-1018-8	2020-07-10	Lovastatin Tablet USP Revision M
63629-1018-9	2020-07-10	Lovastatin Tablet USP Revision M
63629-1018-0	2020-01-31	Lovastatin Tablet USP Revision M
63629-1018-1	2020-01-31	Lovastatin Tablet USP Revision M
63629-1018-2	2020-01-31	Lovastatin Tablet USP Revision M
63629-1018-3	2020-01-31	Lovastatin Tablet USP Revision M
63629-1018-4	2020-01-31	Lovastatin Tablet USP Revision M
63629-1018-5	2020-01-31	Lovastatin Tablet USP Revision M
63629-1018-6	2020-01-31	Lovastatin Tablet USP Revision M
63629-1018-8	2020-01-31	Lovastatin Tablet USP Revision M
63629-1018-9	2020-01-31	Lovastatin Tablet USP Revision M

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63629-1018-0	Lovastatin	1000 in 1 BOTTLE	TABLET	1000	14
63629-1018-1	Lovastatin	100 in 1 BOTTLE	TABLET	100	14
63629-1018-2	Lovastatin	30 in 1 BOTTLE	TABLET	30	14
63629-1018-3	Lovastatin	300 in 1 BOTTLE	TABLET	300	14
63629-1018-4	Lovastatin	120 in 1 BOTTLE	TABLET	120	14
63629-1018-5	Lovastatin	500 in 1 BOTTLE	TABLET	500	14
63629-1018-6	Lovastatin	60 in 1 BOTTLE	TABLET	60	14
63629-1018-8	Lovastatin	800 in 1 BOTTLE	TABLET	800	14
63629-1018-9	Lovastatin	90 in 1 BOTTLE	TABLET	90	14

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63629-1018-3	EA - Each	63629-1018	153165d8-eea6-4002-8a0e-4629347ef680	1	2019-09-05
63629-1018-4	EA - Each	63629-1018	d7f0daa5-af8d-45d3-bc3a-f1e5d5c31133	1	2019-09-05
63629-1018-5	EA - Each	63629-1018	3f3c1838-5a82-42a0-b2ca-bd631aeb451e	1	2019-09-05
63629-1018-6	EA - Each	63629-1018	5b645899-5712-4b0e-bafa-3d9332c44bb2	1	2019-09-05
63629-1018-9	EA - Each	63629-1018	209ff88b-35c5-423d-bef9-4960ac5d9ba3	1	2019-09-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63629-1018	LOVASTATIN TABLET [BRYANT RANCH PREPACK]	14	Current NDC, Legacy NDC, 9 package rows	20240913_c871a6a7-67a4-4ac1-b102-3f1604625c7d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 28 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lovastatin	LOVASTATIN	Bryant Ranch Prepack	a623c1da-e94e-41be-900c-9e74376d36c8	2024-08-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	NuCare Pharmaceuticals, Inc.	4aa44b69-2946-2fb1-e054-00144ff8d46c	2024-07-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	NuCare Pharmaceuticals,Inc.	8ccb2a86-cd02-4162-e053-2995a90abe0e	2024-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Aphena Pharma Solutions - Tennessee, LLC	0399c35c-513d-48e6-aa20-e8434e3b18d5	2024-01-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Proficient Rx LP	da9c25c1-f65c-4dc6-8e13-f727c50fd4e4	2022-09-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Proficient Rx LP	25efd38a-1495-4824-9137-a3429bc471bd	2022-07-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Proficient Rx LP	4b512c0b-b2f6-4a16-bee6-7669195497ad	2021-01-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Proficient Rx LP	c2b1b926-def3-4411-9aed-395b969028fe	2021-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9LHU78OQFD	LOVASTATIN	75330-75-5	LOVASTATIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197903	lovastatin 10 MG Oral Tablet	PSN	c871a6a7-67a4-4ac1-b102-3f1604625c7d	14
197903	lovastatin 10 MG Oral Tablet	SCD	c871a6a7-67a4-4ac1-b102-3f1604625c7d	14

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63629-1018-0	63629101800	1000 TABLET in 1 BOTTLE (63629-1018-0)	1000 tablet	2024-08-14	0000-00-00	No	No	Current
63629-1018-1	63629101801	100 TABLET in 1 BOTTLE (63629-1018-1)	100 tablet	2024-08-14	0000-00-00	No	No	Current
63629-1018-2	63629101802	30 TABLET in 1 BOTTLE (63629-1018-2)	30 tablet	2024-08-14	0000-00-00	No	No	Current
63629-1018-3	63629101803	300 TABLET in 1 BOTTLE (63629-1018-3)	300 tablet	2024-08-14	0000-00-00	No	No	Current
63629-1018-4	63629101804	120 TABLET in 1 BOTTLE (63629-1018-4)	120 tablet	2019-12-16	0000-00-00	No	No	Current
63629-1018-5	63629101805	500 TABLET in 1 BOTTLE (63629-1018-5)	500 tablet	2019-12-10	0000-00-00	No	No	Current
63629-1018-6	63629101806	60 TABLET in 1 BOTTLE (63629-1018-6)	60 tablet	2024-08-14	0000-00-00	No	No	Current
63629-1018-8	63629101808	800 TABLET in 1 BOTTLE (63629-1018-8)	800 tablet	2024-08-14	0000-00-00	No	No	Current
63629-1018-9	63629101809	90 TABLET in 1 BOTTLE (63629-1018-9)	90 tablet	2024-08-14	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Lovastatin Tablet USP Revision M	Bryant Ranch Prepack	2024-09-12	HUMAN PRESCRIPTION DRUG LABEL	14